Biogen reports 6 new cases of PML with Tysabri

The article below is taken directly from Reuters.

If you are taking Tysabri, made by Biogen, we urge you to please go and speak with your doctors as the total number of deaths reported is now at 16, while 69 people remain in varying states of disability from PML–on top of having Multiple Sclerosis. More information on what PML is here at WebMd and here at Wikipedia.

Good source for all MS drugs is: Drugcompare.destinationrx.com.

More Tysabri information herehere and here.

Everything below is taken directly from Reuters.

Biogen reports 6 new cases of PML with Tysabri

(Reuters) – Biogen Idec Inc said six patients taking its multiple sclerosis drug Tysabri developed a potentially fatal brain infection in December, bringing the total number of such cases associated with the drug to 85.

The biotechnology company said that as of January 7, the overall incidence of progressive multifocal leukoecephalopathy, or PML, was 1.06 per 1,000 patients, up from 1.0 in 1,000 last year.

Biogen, which makes the drug with Irish drugmaker Elan Corp Plc, temporarily withdrew Tysabri from the market in 2005 after it was first associated with the condition; it was brought back, with stricter safety warnings, in 2006.

The drug is widely considered the most effective on the market, but its sales have been crimped by concerns over PML. The risk of the condition increases with the length of treatment.

After two years of monthly infusions, the incidence of PML is now 2.13 per 1,000 patients.

The overall rate of PML in clinical trials was 1 in 1000, a benchmark that has now been exceeded.

Of the 85 cases of PML reported, 16 patients have died, while 69 are still alive with varying degrees of disability.

Biogen is developing a test that it hopes will allow doctors to screen patients to identify which might be more likely to develop PML.

Biogen shares were down $2.02 or 2.9 percent to $66.76 in afternoon New York trading, while Elan shares were down 10 cents or 1.5 percent to $6.37.

(Reporting by Toni Clarke, editing by Gerald E. McCormick)

2 thoughts on “Biogen reports 6 new cases of PML with Tysabri

  1. I went off Tysabri after 24 months. Was hospitalized for an unrelated matter, and the blood test upon admission showed my inflammation level was sky-high. You might want to ask your doctor for a CRP (C Reactive Protein) blood test if you are a long time tysabri patient.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s